Auxilium Vitae Rehabilitation Centre
Volterra, 56048, Italy
NCT Number: NCT02496026
The objective of the study is to evaluate the effectiveness of transcranial direct current stimulation (tDCS) integrated with wrist robot-assisted treatment. In detail, the anodal stimulation on the impaired hemisphere will be used associated with a robotic treatment.
Looking for future studies?
Notify Me18 year–79 year
All sexes
Interventional
Not applicable
Volterra, 56048, Italy
As for transcranial direct current stimulation a HDC kit (ATES/EB NEURO, Firenze, Italy) will be used as device. It is a new device generation of stimulator able to provide an effective stimulation pattern.
As robotic device the InMotion wrist robot (Interactive Motion Technologies Inc., Watertown, MA, USA) will be used. It is an end-effector robotic device able to assist as needed the wrist movements.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients receive robotic rehabilitation session while tDCS stimulator is switched on
Patients receive robotic rehabilitation session while tDCS stimulator is switched off.
Time frame: 6 weeks
Impairment level measure according to ICF
Time frame: 6 months
Impairment level measure according to ICF
Time frame: 6 weeks
Impairment level measure according to ICF
Time frame: 6 months
Impairment level measure according to ICF
Time frame: 6 weeks
Impairment level measure according to ICF
Time frame: 6 months
Impairment level measure according to ICF
Time frame: 6 weeks
Activities level measure according to ICF
Time frame: 6 months
Activities level measure according to ICF
Auxilium Vitae Volterra
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03969927
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kansas City, Kansas, United States
View Trial DetailsNCT04685408
Brain Diseases, Cardiovascular Diseases
Kampala, Uganda
View Trial DetailsNCT05016531
Brain Diseases, Cardiovascular Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07751224
Brain Diseases, Cardiovascular Diseases
Ho Chi Minh City, Vietnam
View Trial Details